We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

190 hedge funds and large institutions have $454M invested in Heron Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 15

72% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 39

37% more capital invested

Capital invested by funds: $331M → $454M (+$123M)

18% more funds holding

Funds holding: 161 → 190 (+29)

6.65% more ownership

Funds ownership: 79.39% → 86.04% (+6.7%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

32% less call options, than puts

Call options by funds: $532K | Put options by funds: $781K

Holders
190
Holders Change
+29
Holders Change %
+18.01%
% of All Funds
2.74%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
45
Increased
67
Reduced
39
Closed
15
Calls
$532K
Puts
$781K
Net Calls
-$249K
Net Calls Change
-$4.55M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.4M
2
State Street
State Street
Massachusetts
+$8.73M
3
Marshall Wace
Marshall Wace
United Kingdom
+$3.89M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.59M
5
BlackRock
BlackRock
New York
+$3.19M

Top Sellers

1
O
OrbiMed
New York
-$11.1M
2
Millennium Management
Millennium Management
New York
-$5.32M
3
CC
Clearline Capital
New York
-$3.94M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.27M
5
MAM
Monaco Asset Management
Monaco
-$922K
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
101
Prudential Financial
New Jersey
$107K +$54K +17,580 +136%
HS
102
Horan Securities
United States
$103K +$90K +29,310 New
SPIA
103
Steward Partners Investment Advisory
New York
$96.3K +$81.5K +26,525 +2,653%
State Board of Administration of Florida Retirement System
104
State Board of Administration of Florida Retirement System
Florida
$94.1K -$42.4K -13,811 -34%
Balyasny Asset Management
105
Balyasny Asset Management
Illinois
$94K +$82.5K +26,868 New
PHS
106
Pekin Hardy Strauss
Illinois
$88.1K -$18.4K -6,000 -19%
Verition Fund Management
107
Verition Fund Management
Connecticut
$86K +$75.5K +24,573 New
DT
108
Diversified Trust
Tennessee
$83.9K – – –
DWM
109
Dakota Wealth Management
Florida
$83.8K – – –
GCM
110
Graham Capital Management
Connecticut
$78.1K +$68.5K +22,304 New
AA
111
ACT Advisors
North Carolina
$77.5K – – –
CWC
112
Carolinas Wealth Consulting
North Carolina
$76.4K +$6.54K +2,130 +11%
GT
113
Glenmede Trust
Pennsylvania
$74.6K +$15.8K +5,135 +32%
A
114
AJOVista
Massachusetts
$69K +$60.6K +19,718 New
Envestnet Asset Management
115
Envestnet Asset Management
Illinois
$67K +$3.56K +1,158 +6%
Principal Financial Group
116
Principal Financial Group
Iowa
$64.6K -$54.6K -17,758 -49%
Victory Capital Management
117
Victory Capital Management
Texas
$63K -$2.3K -750 -4%
DIM
118
DLK Investment Management
California
$62.6K – – –
Royal Bank of Canada
119
Royal Bank of Canada
Ontario, Canada
$61K +$15.9K +5,172 +43%
DB
120
Danske Bank
Denmark
$57.3K – – –
EGM
121
Engineers Gate Manager
New York
$56.7K -$181K -58,946 -78%
ACH
122
ArrowMark Colorado Holdings
Colorado
$56.4K – – –
EFM
123
E Fund Management
China
$54.7K +$48.1K +15,642 New
KWMG
124
King Wealth Management Group
Florida
$54K +$16K +5,200 +51%
Cetera Investment Advisers
125
Cetera Investment Advisers
Illinois
$52.9K +$4.92K +1,602 +12%
3 4
5
6 7

HRTX Hedge Fund Activity: Q2 2024 in Review

190 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2024, worth a combined $454M — up 37% from $331M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new HRTX positions and 15 closed out — a net gain of 30 holders — while 67 added to existing stakes and 39 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $14.4M. The largest seller was OrbiMed, cutting an estimated $11.1M.

  • 190 institutional investors held Heron Therapeutics (HRTX) as of Q2 2024, up from 161 in Q1 2024.
  • Funds reported $454M of Heron Therapeutics stock for Q2 2024, up 37% quarter-over-quarter.
  • 45 funds opened new Heron Therapeutics positions in Q2 2024 and 15 closed out, a net change of +30 holders.
  • The largest Heron Therapeutics buyer in Q2 2024 was Adage Capital Partners, an estimated $14.4M added.
  • The largest Heron Therapeutics seller in Q2 2024 was OrbiMed, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2024.